Physician profile
Russell Stankiewicz
NPI 1891773875
$201,524.83
in general payments reported to CMS, 2019-2025
20 companies · $52K in 2025
The $52K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $21K · 2021: $10K · 2022: $11K · 2023: $22K · 2024: $23K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $65K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Travel and Lodging: $7,663 · Food and Beverage: $2,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $65,197.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,360.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,265.74 |
| Travel and Lodging | $7,662.90 |
| Food and Beverage | $2,141.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $84,316.92 | 2019-2025 | Stratafix, Dermabond Prineo, Harmonic |
| Ethicon US, LLC | $38,492.84 | 2019-2025 | Stratafix, Dermabond Prineo, Enseal |
| Hologic Sales and Service, LLC | $26,868.68 | 2019-2020 | |
| Organon LLC | $20,764.72 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $13,095.36 | 2019-2024 | Veozah |
| Merck Sharp & Dohme LLC | $10,162.40 | 2019-2021 | |
| Ethicon INC. | $6,366.10 | 2022-2025 | |
| Momentis Surgical INC. | $816.24 | 2021-2022 | |
| Abbvie INC. | $303.33 | 2019-2025 | |
| Olympus Corporation of The Americas | $84.87 | 2019 | |
| Pfizer INC. | $45.04 | 2019-2022 | |
| Aesculap, INC. | $40.42 | 2019 | |
| Therapeuticsmd, INC. | $30.22 | 2019 | |
| Alydia Health | $30.01 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.52 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $17.42 | 2023 | Olympus |
| Allergan, INC. | $16.75 | 2019 | |
| Millicent US INC | $16.73 | 2025 | Intrarosa, Femring |
| Avion Pharmaceuticals | $14.99 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Stankiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.